MAKAP compartmentalizes oxygen-dependent control of HIF-1α

Science Signaling

Volumn 1, Issue 51, 2008, Pages

  Wong, Wei ^a   Goehring, April S ^a   Kapiloff, Michael S ^b   Langeberg, Lorene K ^c   Scott, John D ^c  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AKAP6 PROTEIN, HUMAN; CYCLIC AMP DEPENDENT PROTEIN KINASE ANCHORING PROTEIN; HYPOXIA INDUCIBLE FACTOR 1ALPHA; OXYGEN; UBIQUITIN PROTEIN LIGASE; UNCLASSIFIED DRUG;

ANOXIA; ARTICLE; CELL COMPARTMENTALIZATION; CELL LINE; CELL NUCLEUS; HEART MUSCLE CELL; HUMAN; METABOLISM; PHYSIOLOGY; PROTEIN STABILITY;

A KINASE ANCHOR PROTEINS; ANOXIA; CELL COMPARTMENTATION; CELL LINE; CELL NUCLEUS; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MYOCYTES, CARDIAC; OXYGEN; PROTEIN STABILITY; UBIQUITIN-PROTEIN LIGASES;

EID: 58749099474     PISSN: 19450877     EISSN: 19379145     Source Type: Journal    
DOI: 10.1126/scisignal.2000026     Document Type: Article

References (48)

1. F. J. Giordano, Oxygen, oxidative stress, hypoxia, and heart failure. J. Clin. Invest. 115, 500-508 (2005).
2. G. L. Semenza, HIF-1 and mechanisms of hypoxia sensing. Curr. Opin. Cell Biol. 13, 167-171 (2001).
3. M. Ohh, C.W. Park, M. Ivan, M. A. Hoffman, T. Y. Kim, L. E. Huang, N. Pavletich, V. Chau, W. G. Kaelin, Ubiquitination of hypoxia-inducible factor requires direct binding to the b-domain of the von Hippel-Lindau protein. Nat. Cell Biol. 2, 423-427 (2000).
4. P. Jaakkola, D. R. Mole, Y. M. Tian, M. I. Wilson, J. Gielbert, S. J. Gaskell, A. von Kriegsheim, H. F. Hebestreit, M. Mukherji, C. J. Schofield, P. H. Maxwell, C. W. Pugh, P. J. Ratcliffe, Targeting of HIF-A to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation. Science 292, 468-472 (2001).
5. A. C. Epstein, J. M. Gleadle, L. A. McNeill, K. S. Hewitson, J. O'Rourke, D. R. Mole, M. Mukherji, E. Metzen, M. I. Wilson, A. Dhanda, Y. M. Tian, N. Masson, D. L. Hamilton, P. Jaakkola, R. Barstead, J. Hodgkin, P. H. Maxwell, C. W. Pugh, C. J. Schofield, P. J. Ratcliffe, C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation. Cell 107, 43-54 (2001).
6. P. H. Maxwell, M. S. Wiesener, G. W. Chang, S. C. Clifford, E. C. Vaux, M. E. Cockman, C. C. Wykoff, C. W. Pugh, E. R. Maher, P. J. Ratcliffe, The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature 399, 271-275 (1999).
7. K. Nakayama, I. J. Frew, M. Hagensen, M. Skals, H. Habelhah, A. Bhoumik, T. Kadoya, H. Erdjument-Bromage, P. Tempst, P. B. Frappell, D. D. Bowtell, Z. Ronai, Siah2 regulates stability of prolyl-hydroxylases, controls HIF1a abundance, and modulates physiological responses to hypoxia. Cell 117, 941-952 (2004).
8. G. L. Wang, B. H. Jiang, E. A. Rue, G. L. Semenza, Hypoxia-inducible factor 1 is a basichelix-loop-helix-PAS heterodimer regulated by cellular O2 tension. Proc. Natl. Acad. Sci. U.S.A. 92, 5510-5514 (1995).
9. G. L. Wang, G. L. Semenza, Purification and characterization of hypoxia-inducible factor 1. J. Biol. Chem. 270, 1230-1237 (1995).
10. M. Y. Koh, T. R. Spivak-Kroizman, G. Powis, HIF-1 regulation: Not so easy come, easy go. Trends Biochem. Sci. 33, 526-534 (2008).
11. R. H. Wenger, M. Gassmann, Oxygen(es) and the hypoxia-inducible factor-1. Biol. Chem. 378, 609-616 (1997).
12. S. H. Lee, P. L. Wolf, R. Escudero, R. Deutsch, S. W. Jamieson, P. A. Thistlethwaite, Early expression of angiogenesis factors in acute myocardial ischemia and infarction. N. Engl. J. Med. 342, 626-633 (2000).
13. W. Wong, J. D. Scott, AKAP signalling complexes: Focal points in space and time. Nat. Rev. Mol. Cell Biol. 5, 959-970 (2004).
14. K. L. Dodge, S. Khouangsathiene, M. S. Kapiloff, R. Mouton, E. V. Hill, M. D. Houslay, L. K. Langeberg, J. D. Scott, mAKAP assembles a protein kinase A/PDE4 phosphodiesterase cAMP signaling module. EMBO J. 20, 1921-1930 (2001).
15. S. H. Soderling, K. L. Binns, G. A. Wayman, S. M. Davee, S. H. Ong, T. Pawson, J. D. Scott, The WRP component of the WAVE-1 complex attenuates Rac-mediated signalling. Nat. Cell Biol. 4, 970-975 (2002).
16. D. Diviani, J.Soderling, J. D. Scott, AKAP-Lbc anchors protein kinaseAand nucleatesGa12-selective Rho-mediated stress fiber formation. J. Biol. Chem. 276, 44247-44257 (2001).
17. I. D. Fraser, M. Cong, J. Kim, E. N. Rollins, Y. Daaka, R. J. Lefkowitz, J. D. Scott, Assembly of an A kinase-Anchoring protein-b2-Adrenergic receptor complex facilitates receptor phosphorylation and signaling. Curr. Biol. 10, 409-412 (2000).
18. J. J. Michel, I. K. Townley, K. L. Dodge-Kafka, F. Zhang, M. S. Kapiloff, J. D. Scott, Spatial restriction of PDK1 activation cascades by anchoring to mAKAPa. Mol. Cell 20, 661-672 (2005).
19. B. Lygren, C. R. Carlson, K. Santamaria, V. Lissandron, T. McSorley, J. Litzenberg, D. Lorenz, B. Wiesner, W. Rosenthal, M. Zaccolo, K. Taskén, E. Klussmann, AKAP complex regulates Ca2+ re-uptake into heart sarcoplasmic reticulum. EMBO Rep. 8, 1061-1067 (2007).
20. M. F. Navedo, M. Nieves-Cintron, G. C. Amberg, C. Yuan, V. S. Votaw, W. J. Lederer, G. S. McKnight, L. F. Santana, AKAP150 is required for stuttering persistent Ca2+ sparklets and angiotensin II-induced hypertension. Circ. Res. 102, e1-e11 (2008).
21. G. K. Carnegie, J. Soughayer, F. D. Smith, B. S. Pedroja, F. Zhang, D. Diviani, M. R. Bristow, M. T. Kunkel, A. C. Newton, L. K. Langeberg, J. D. Scott, AKAP-Lbc mobilizes a cardiac hypertrophy signaling pathway. Mol. Cell 32, 169-179 (2008).
22. C. J. Schofield, P. J. Ratcliffe, Oxygen sensing by HIF hydroxylases. Nat. Rev. Mol. Cell Biol. 5, 343-354 (2004).
23. M. E. Lieb, K. Menzies, M. C. Moschella, R. Ni, M. B. Taubman, Mammalian EGLN genes have distinct patterns of mRNA expression and regulation. Biochem. Cell Biol. 80, 421-426 (2002).
24. E. Berra, E. Benizri, A. Ginouvès, V. Volmat, D. Roux, J. Pouysségur, HIF prolylhydroxylase 2 is the key oxygen sensor setting low steady-state levels of HIF-1a in normoxia. EMBO J. 22, 4082-4090 (2003).
25. R. J. Appelhoff, Y.-M. Tian, R. R. Raval, H. Turley, A. L. Harris, C. W. Pugh, P. J. Ratcliffe, J. M. Gleadle, Differential function of the prolyl hydroxylases PHD1, PHD2, and PHD3 in the regulation of hypoxia-inducible factor. J. Biol. Chem. 279, 38458-38465 (2004).
26. G. Hu, E. R. Fearon, Siah-1 N-Terminal RING domain is required for proteolysis function, and C-Terminal sequences regulate oligomerization and binding to target proteins. Mol. Cell Biol. 19, 724-732 (1999).
27. G. Polekhina, C. M. House, N. Traficante, J. P. Mackay, F. Relaix, D. A. Sassoon, M. W. Parker, D. D. Bowtell, Siah ubiquitin ligase is structurally related to TRAF and modulates TNF-A signaling. Nat. Struct. Biol. 9, 68-75 (2002).
28. K. L. Dodge-Kafka, J. Soughayer, G. C. Pare, J. J. Carlisle Michel, L. K. Langeberg, M. S. Kapiloff, J. D. Scott, The protein kinase A anchoring protein mAKAP coordinates two integrated cAMP effector pathways. Nature 437, 574-578 (2005).
29. B. L. Ebert, J. D. Firth, P. J. Ratcliffe, Hypoxia and mitochondrial inhibitors regulate expression of glucose transporter-1 via distinct cis-Acting sequences. J. Biol. Chem. 270, 29083-29089 (1995).
30. J. A. Forsythe, B. H. Jiang, N. V. Iyer, F. Agani, S.W. Leung, R. D. Koos, G. L. Semenza, Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Mol. Cell Biol. 16, 4604-4613 (1996).
31. G. C. Pare, J. L. Easlick, J. M. Mislow, E. M. McNally, M. S. Kapiloff, Nesprin-1a contributes to the targeting of mAKAP to the cardiac myocyte nuclear envelope. Exp. Cell Res. 303, 388-399 (2005).
32. G. L. Semenza, F. Agani, D. Feldser,N. Iyer, L.Kotch,E. Laughner,A.Yu,Hypoxia,HIF-1, and the pathophysiology of common human diseases. Adv. Exp.Med. Biol. 475, 123-130 (2000).
33. M. Colledge, E. M. Snyder, R. A. Crozier, J. A. Soderling, Y. Jin, L. K. Langeberg, H. Lu, M. F. Bear, J. D. Scott, Ubiquitination regulates PSD-95 degradation and AMPA receptor surface expression. Neuron 40, 595-607 (2003).
34. A. Carlucci, A. Adornetto, A. Scorziello, D. Viggiano, M. Foca, O. Cuomo, L. Annunziato, M. Gottesman, A. Feliciello, Proteolysis of AKAP121 regulates mitochondrial activity during cellular hypoxia and brain ischaemia. EMBO J. 27, 1073-1084 (2008).
35. M. S. Kapiloff, R. V. Schillace, A. M. Westphal, J. D. Scott, mAKAP: An A-kinase anchoring protein targeted to the nuclear membrane of differentiated myocytes. J. Cell Sci. 112, 2725-2736 (1999).
36. K. Tasken, E. M. Aandahl, Localized effects of cAMP mediated by distinct routes of protein kinase A. Physiol. Rev. 84, 137-167 (2004).
37. R. S. Westphal, S. J. Tavalin, J. W. Lin, N. M. Alto, I. D. Fraser, L. K. Langeberg, M. Sheng, J. D. Scott, Regulation of NMDA receptors by an associated phosphatasekinase signaling complex. Science 285, 93-96 (1999).
38. N. Hoshi, L. K. Langeberg, J. D. Scott, Distinct enzyme combinations in AKAP signalling complexes permit functional diversity. Nat. Cell Biol. 7, 1066-1073 (2005).
39. A. L. Bauman, J. Soughayer, B. T. Nguyen, D. Willoughby, G. K. Carnegie, W. Wong, N. Hoshi, L. K. Langeberg, D. M. Cooper, C. W. Dessauer, J. D. Scott, Dynamic regulation of cAMP synthesis through anchored PKA-Adenylyl cyclase V/VI complexes. Mol. Cell 23, 925-931 (2006).
40. D. Willoughby,W.Wong, J. Schaack, J. D. Scott, D. M. Cooper,An anchoredPKAandPDE4 complex regulates subplasmalemmal cAMP dynamics. EMBO J. 25, 2051-2061 (2006).
41. B. J. Tunquist, N. Hoshi, E. S. Guire, F. Zhang, K. Mullendorff, L. K. Langeberg, J. Raber, J. D. Scott, Loss of AKAP150 perturbs distinct neuronal processes in mice. Proc. Natl. Acad. Sci. U.S.A. 105, 12557-12562 (2008).
42. M. Sano, T. Minamino, H. Toko, H. Miyauchi, M. Orimo, Y. Qin, H. Akazawa, K. Tateno, Y. Kayama, M. Harada, I. Shimizu, T. Asahara, H. Hamada, S. Tomita, J. D. Molkentin, Y. Zou, I. Komuro, p53-induced inhibition of Hif-1 causes cardiac dysfunction during pressure overload. Nature 446, 444-448 (2007).
43. R. L. Nicol, N. Frey, G. Pearson, M. Cobb, J. Richardson, E. N. Olson, Activated MEK5 induces serial assembly of sarcomeres and eccentric cardiac hypertrophy. EMBO J. 20, 2757-2767 (2001).
44. X. Pi, G. Garin, L. Xie, Q. Zheng, H. Wei, J. Abe, C. Yan, B. C. Berk, BMK1/ERK5 is a novel regulator of angiogenesis by destabilizing hypoxia inducible factor 1a. Circ. Res. 96, 1145-1151 (2005).
45. N. Masson, C. Willam, P. H. Maxwell, C. W. Pugh, P. J. Ratcliffe, Independent function of two destruction domains in hypoxia-inducible factor-A chains activated by prolyl hydroxylation. EMBO J. 20, 5197-5206 (2001).
46. B. Hu, N. G. Copeland, D. J. Gilbert, N. A. Jenkins, M. W. Kilimann, The paralemmin protein family: Identification of paralemmin-2, an isoform differentially spliced to AKAP2/ AKAP-KL, and of palmdelphin, a more distant cytosolic relative. Biochem. Biophys. Res. Commun. 285, 1369-1376 (2001).
47. G. C. Pare, A. L. Bauman, M. McHenry, J. J. Michel, K. L. Dodge-Kafka, M. S. Kapiloff, The mAKAP complex participates in the induction of cardiac myocyte hypertrophy by adrenergic receptor signaling. J. Cell Sci. 118, 5637-5646 (2005).
48. J. J. Carlisle Michel, K. L. Dodge, W. Wong, N. C. Mayer, L. K. Langeberg, J. D. Scott, PKA-phosphorylation of PDE4D3 facilitates recruitment of the mAKAP signalling complex. Biochem. J. 381, 587-592 (2004).